Heparanase: A Potential Therapeutic Target in Sarcomas

Area of Science:

• Oncology
• Biochemistry
• Molecular Biology

Background:

• Sarcomas are rare, heterogeneous cancers originating from connective tissues, posing diagnostic and therapeutic challenges.
• Heparanase deregulation and altered heparan sulfate proteoglycans are observed in several sarcoma subtypes, correlating with poor prognosis.
• Heparan sulfate-binding growth factors and receptor tyrosine kinases are crucial for sarcoma progression.

Purpose of the Study:

• To review the biological significance of heparanase expression in sarcomas.
• To explore heparanase as a potential therapeutic target in soft tissue and bone sarcomas.
• To highlight the role of heparan sulfate proteoglycans and related enzymes in bone sarcoma pathobiology.

Main Methods:

• Literature review of heparanase and heparan sulfate involvement in sarcoma.
• Analysis of molecular pathogenesis in various sarcoma subtypes.
• Examination of preclinical evidence for therapeutic targeting.

Main Results:

• High heparanase expression correlates with poor prognosis in Ewing's sarcoma and osteosarcoma.
• Altered heparan sulfate proteoglycans and biosynthetic enzymes are linked to sarcoma development.
• Cooperation between exostin loss-of-function and heparanase upregulation contributes to malignant transformation in Multiple Osteochondroma syndrome.

Conclusions:

• Interference with heparanase/heparan sulfate functions presents a viable therapeutic approach for sarcomas.
• Heparanase is a promising therapeutic target in various soft tissue and bone sarcoma subtypes.
• Understanding the heparanase/heparan sulfate system is key to developing novel sarcoma treatments.